Molecular genetics of anxiety in mice and men

Annals of Medicine

Volumn 40, Issue 2, 2008, Pages 92-109

  Hovatta, Iiris ^a,b,c   Barlow, Carrolee ^d  

^a BIOMEDICUM HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d BrainCells Inc   (United States)

Author keywords

Anxiety; Anxiety disorders; Gene expression profiling; Genetic association; Linkage analysis; Mouse model; Personality trait; QTL mapping; Susceptibility gene

Indexed keywords

ANXIETY DISORDER; DISEASE MODEL; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FUNCTIONAL GENOMICS; GENE FUNCTION; GENE IDENTIFICATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENOME; HEREDITY; HUMAN; MOLECULAR GENETICS; MOUSE STRAIN; NONHUMAN; PERSONALITY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW;

ANIMALS; ANXIETY; ANXIETY DISORDERS; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MICE; MOLECULAR BIOLOGY; QUANTITATIVE TRAIT LOCI;

EID: 43149099436     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890701747096     Document Type: Review

References (149)

1. Gratacos M, Sahun I, Gallego X, Amador-Arjona A, Estivill X, Dierssen M. Candidate genes for panic disorder: insight from human and mouse genetic studies. Genes Brain Behav. 2007;6Suppl 1:2-23.
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-27.
3. Pirkola SP, Isometsa E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population-results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol. 2005;40:1-10.
4. Shih RA, Belmonte PL, Zandi PP. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry. 2004;16:260-83.
5. Smoller JW, Finn C, White C. The genetics of anxiety disorders: an overview. Psychiatr Ann. 2000;30:745-53.
6. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158:1568-78.
7. Eysenck HJ, Eysenck MJ. Personality and individual differences: a natural science approach. New York: Plenum; 1985.
8. Kirk KM, Birley AJ, Statham DJ, Haddon B, Lake RI, Andrews JG, et al. Anxiety and depression in twin and sib pairs extremely discordant and concordant for neuroticism: prodromus to a linkage study. Twin Res. 2000;3:299-309.
9. Jardine R, Martin NG, Henderson AS. Genetic covariation between neuroticism and the symptoms of anxiety and depression. Genet Epidemiol. 1984;1:89-107.
10. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry. 2006;163:857-64.
11. Hettema JM, Prescott CA, Kendler KS. Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am J Psychiatry. 2004;161:1581-7.
12. Costa PT Jr, McCrae RR. Stability and change in personality assessment: the revised NEO Personality Inventory in the year 2000. J Pers Assess. 1997;68:86-94.
13. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986;4:167-226.
14. Ebstein RP. The molecular genetic architecture of human personality: beyond self-report questionnaires. Mol Psychiatry. 2006;11:427-45.
15. Lake RI, Eaves LJ, Maes HH, Heath AC, Martin NG. Further evidence against the environmental transmission of individual differences in neuroticism from a collaborative study of 45,850 twins and relatives on two continents. Behav Genet. 2000;30:223-33.
16. Bremner JD. Brain imaging in anxiety disorders. Expert Rev Neurother. 2004;4:275-84.
17. Deckersbach T, Dougherty DD, Rauch SL. Functional imaging of mood and anxiety disorders. J Neuroimaging. 2006;16:1-10.
18. Mitterschiffthaler MT, Ettinger U, Mehta MA, Mataix-Cols D, Williams SC. Applications of functional magnetic resonance imaging in psychiatry. J Magn Reson Imaging. 2006;23:851-61.
19. Pearlson GD, Calhoun V. Structural and functional magnetic resonance imaging in psychiatric disorders. Can J Psychiatry. 2007;52:158-66.
20. Fan JB, Chee MS, Gunderson KL. Highly parallel genomic assays. Nat Rev Genet. 2006;7:632-44.
21. Shifman S, Bhomra A, Smiley S, Wray NR, James MR, Martin NG, et al., A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry. 2007 Jul 31. Epub ahead of print, .
22. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993;52:506-16.
23. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;361:598-604.
24. Goring HH, Terwilliger JD. Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. Am J Hum Genet. 2000;66:1310-27.
25. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114:541-52.
26. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, et al. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry. 2006;11:763-70.
27. Knowles JA, Fyer AJ, Vieland VJ, Weissman MM, Hodge SE, Heiman GA, et al. Results of a genome-wide genetic screen for panic disorder. Am J Med Genet. 1998;81:139-47.
28. Crowe RR, Goedken R, Samuelson S, Wilson R, Nelson J, Noyes R Jr. Genomewide survey of panic disorder. Am J Med Genet. 2001;105:105-9.
29. Gelernter J, Bonvicini K, Page G, Woods SW, Goddard AW, Kruger S, et al. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet. 2001;105:548-57.
30. Hamilton SP, Fyer AJ, Durner M, Heiman GA, Baisre de Leon A, Hodge SE, et al. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci U S A. 2003;100:2550-5.
31. Thorgeirsson TE, Oskarsson H, Desnica N, Kostic JP, Stefansson JG, Kolbeinsson H, et al. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am J Hum Genet. 2003;72:1221-30.
32. Gelernter J, Page GP, Bonvicini K, Woods SW, Pauls DL, Kruger S. A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan. Mol Psychiatry. 2003;8:71-82.
33. Gelernter J, Page GP, Stein MB, Woods SW. Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. Am J Psychiatry. 2004;161:59-66.
34. Kaabi B, Gelernter J, Woods SW, Goddard A, Page GP, Elston RC. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am J Hum Genet. 2006;78:543-53.
35. Cloninger CR, Van Eerdewegh P, Goate A, Edenberg HJ, Blangero J, Hesselbrock V, et al. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet. 1998;81:313-7.
36. Fullerton J, Cubin M, Tiwari H, Wang C, Bomhra A, Davidson S, et al. Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am J Hum Genet. 2003;72:879-90.
37. Nash MW, Huezo-Diaz P, Williamson RJ, Sterne A, Purcell S, Hoda F, et al. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum Mol Genet. 2004;13:2173-82.
38. Neale BM, Sullivan PF, Kendler KS. A genome scan of neuroticism in nicotine dependent smokers. Am J Med Genet B Neuropsychiatr Genet. 2005;132:65-9.
39. Willour VL, Yao Shugart Y, Samuels J, Grados M, Cullen B, Bienvenu OJ 3rd, et al. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet. 2004;75:508-13.
40. Dina C, Nemanov L, Gritsenko I, Rosolio N, Osher Y, Heresco-Levy U, et al. Fine mapping of a region on chromosome 8p gives evidence for a QTL contributing to individual differences in an anxiety-related personality trait: TPQ harm avoidance. Am J Med Genet B Neuropsychiatr Genet. 2005;132:104-8.
41. Wacker J, Reuter M, Hennig J, Stemmler G. Sexually dimorphic link between dopamine D2 receptor gene and neuroticism-anxiety. Neuroreport. 2005;16:611-4.
42. Billett EA, Richter MA, Sam F, Swinson RP, Dai XY, King N, et al. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr Genet. 1998;8:163-9.
43. Millet B, Chabane N, Delorme R, Leboyer M, Leroy S, Poirier MF, et al. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2003;116:55-9.
44. Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K, et al. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet. 2005;15:17-24.
45. Van Gestel S, Forsgren T, Claes S, Del-Favero J, Van Duijn CM, Sluijs S, et al. Epistatic effect of genes from the dopamine and serotonin systems on the temperament traits of novelty seeking and harm avoidance. Mol Psychiatry. 2002;7:448-50.
46. Tochigi M, Hibino H, Otowa T, Kato C, Marui T, Ohtani T, et al. Association between dopamine D4 receptor (DRD4) exon III polymorphism and Neuroticism in the Japanese population. Neurosci Lett. 2006;398:333-6.
47. Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF, et al. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry. 2002;51:591-601.
48. Domschke K, Freitag CM, Kuhlenbaumer G, Schirmacher A, Sand P, Nyhuis P, et al. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol. 2004;7:183-8.
49. Woo JM, Yoon KS, Choi YH, Oh KS, Lee YS, Yu BH. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. J Psychiatr Res. 2004;38:365-70.
50. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet. 2003;13:33-41.
51. McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De Vivo I. Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry. 2004;161:1703-5.
52. Olsson CA, Anney RJ, Lotfi-Miri M, Byrnes GB, Williamson R, Patton GC. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatr Genet. 2005;15:109-15.
53. Stein MB, Fallin MD, Schork NJ, Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacol. 2005;30:2092-102.
54. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet. 1999;8:621-4.
55. Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P, Moller HJ, et al. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet. 2003;117:1-6.
56. Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepien G, Grzywacz A, et al. Association studies of MAOA, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Res. 2004;128:21-6.
57. Enoch MA, Greenberg BD, Murphy DL, Goldman D. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry. 2001;49:385-8.
58. Walitza S, Wewetzer C, Warnke A, Gerlach M, Geller F, Gerber G, et al. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry. 2002;7:1054-7.
59. Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav. 2004;3:75-9.
60. Inada Y, Yoneda H, Koh J, Sakai J, Himei A, Kinoshita Y, et al. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res. 2003;118:25-31.
61. McDougle CJ, Epperson CN, Price LH, Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry. 1998;3:270-3.
62. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, et al. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry. 1999;4:463-6.
63. Lee HJ, Lee MS, Kang RH, Kim H, Kim SD, Kee BS, et al. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety. 2005;21:135-9.
64. Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K. A variable-number- tandem-repeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:55-65.
65. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-31.
66. Munafo MR, Clark T, Flint J. Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry. 2005;10:415-9.
67. Gutknecht L, Jacob C, Strobel A, Kriegebaum C, Muller J, Zeng Y, et al. Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol. 2007;10:309-20.
68. Reuter M, Kuepper Y, Hennig J. Association between a polymorphism in the promoter region of the TPH2 gene and the personality trait of harm avoidance. Int J Neuropsychopharmacol. 2007;10:401-4.
69. Hettema JM, An SS, Neale MC, Bukszar J, van den Oord EJ, Kendler KS, et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry. 2006;11:752-62.
70. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63:778-85.
71. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63:769-76.
72. Lee YJ, Hohoff C, Domschke K, Sand P, Kuhlenbaumer G, Schirmacher A, et al. Norepinephrine transporter (NET) promoter and 5′-UTR polymorphisms: association analysis in panic disorder. Neurosci Lett. 2005;377:40-3.
73. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, et al. Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry. 1999;4:284-5.
74. Hosing VG, Schirmacher A, Kuhlenbaumer G, Freitag C, Sand P, Schlesiger C, et al., Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm Suppl. ;2004:147-56.
75. Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M, et al. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry. 1998;3:81-5.
76. Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE, et al. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacol. 2004;29:558-65.
77. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet. 2003;73:370-6.
78. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacol. 2005;30:1353-61.
79. Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, et al. The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry. 2005;57:1485-92.
80. Domschke K, Kuhlenbaumer G, Schirmacher A, Lorenzi C, Armengol L, DiBella D, et al. Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2003;117:70-8.
81. Hamilton SP, Slager SL, Mayo D, Heiman GA, Klein DF, Hodge SE, et al. Investigation of polymorphisms in the CREM gene in panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2004;126:111-5.
82. Ho HP, Westberg L, Annerbrink K, Olsson M, Melke J, Nilsson S, et al. Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinol. 2004;29:1138-41.
83. Olsson M, Annerbrink K, Westberg L, Melke J, Baghaei F, Rosmond R, et al. Angiotensin-related genes in patients with panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2004;127:81-4.
84. Wray NR, James MR, Mah SP, Nelson M, Andrews G, Sullivan PF, et al. Anxiety and comorbid measures associated with PLXNA2. Arch Gen Psychiatry. 2007;64:318-26.
85. Middeldorp CM, de Geus EJ, Beem AL, Lakenberg N, Hottenga JJ, Slagboom PE, et al. Family Based Association Analyses between the Serotonin Transporter Gene Polymorphism (5-HTTLPR) and Neuroticism, Anxiety and Depression. Behav Genet. 2007;37:294-301.
86. Willis-Owen SA, Turri MG, Munafo MR, Surtees PG, Wainwright NW, Brixey RD, et al. The serotonin transporter length polymorphism, neuroticism, and depression: a comprehensive assessment of association. Biol Psychiatry. 2005;58:451-6.
87. Schinka JA, Busch RM, Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry. 2004;9:197-202.
88. Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet. 2004;127:85-9.
89. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-9.
90. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry. 2005;62:529-35.
91. Serretti A, Calati R, Mandelli L, De Ronchi D. Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets. 2006;7:1659-69.
92. Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci. 2006;10:182-91.
93. Nesse RM. Proximate and evolutionary studies of anxiety, stress and depression: synergy at the interface. Neurosci Biobehav Rev. 1999;23:895-903.
94. Stein DJ, Bouwer C. A neuro-evolutionary approach to the anxiety disorders. J Anxiety Disord. 1997;11:409-29.
95. Jones I, Blackshaw JK. An evolutionary approach to psychiatry. Aust N Z J Psychiatry. 2000;34:8-13.
96. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res. 2001;125:141-9.
97. Blanchard DC, Griebel G, Blanchard RJ. The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. Eur J Pharmacol. 2003;463:97-116.
98. Bourin M, Hascoet M. The mouse light/dark box test. Eur J Pharmacol. 2003;463:55-65.
99. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980;13:167-70.
100. Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 1999;835:18-26.
101. Kalueff AV, Wheaton M, Murphy DL. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res. 2007;179:1-18.
102. Adriaan Bouwknecht J, Olivier B, Paylor RE. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci Biobehav Rev. 2007;31:41-59.
103. Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov. 2005;4:775-90.
104. Dulawa SC, Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev. 2005;29:771-83.
105. Gordon JA, Hen R. Genetic approaches to the study of anxiety. Annu Rev Neurosci. 2004;27:193-222.
106. Flint J. Animal models of anxiety and their molecular dissection. Semin Cell Dev Biol. 2003;14:37-42.
107. Finn DA, Rutledge-Gorman MT, Crabbe JC. Genetic animal models of anxiety. Neurogenet. 2003;4:109-35.
108. Gross C, Hen R. The developmental origins of anxiety. Nat Rev Neurosci. 2004;5:545-52.
109. Howell MP, Muglia LJ. Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice. Front Neuroendocrinol. 2006;27:275-84.
110. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A. 1998;95:15049-54.
111. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A. 1998;95:10734-9.
112. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, et al. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A. 1998;95:14476-81.
113. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature. 2002;416:396-400.
114. Tsetsenis T, Ma XH, Lo Iacono L, Beck SG, Gross C. Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus. Nat Neurosci. 2007;10:896-902.
115. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacol (Berl). 1997;132:107-24.
116. Turri MG, Datta SR, DeFries J, Henderson ND, Flint J. QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice. Curr Biol. 2001;11:725-34.
117. Henderson ND, Turri MG, DeFries JC, Flint J. QTL analysis of multiple behavioral measures of anxiety in mice. Behav Genet. 2004;34:267-93.
118. Flint J, Valdar W, Shifman S, Mott R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet. 2005;6:271-86.
119. Yalcin B, Willis-Owen SA, Fullerton J, Meesaq A, Deacon RM, Rawlins JN, et al. Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. Nat Genet. 2004;36:1197-202.
120. Flint J, Corley R, DeFries JC, Fulker DW, Gray JA, Miller S, et al. A simple genetic basis for a complex psychological trait in laboratory mice. Science. 1995;269:1432-5.
121. Talbot CJ, Nicod A, Cherny SS, Fulker DW, Collins AC, Flint J. High-resolution mapping of quantitative trait loci in outbred mice. Nat Genet. 1999;21:305-8.
122. Valdar W, Solberg LC, Gauguier D, Burnett S, Klenerman P, Cookson WO, et al. Genome-wide genetic association of complex traits in heterogeneous stock mice. Nat Genet. 2006;38:879-87.
123. Carter TA, Del Rio JA, Greenhall JA, Latronica ML, Lockhart DJ, Barlow C. Chipping away at complex behavior: transcriptome/phenotype correlations in the mouse brain. Physiol Behav. 2001;73:849-57.
124. Lockhart DJ, Barlow C. Expressing what's on your mind: DNA arrays and the brain. Nat Rev Neurosci. 2001;2:63-8.
125. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, et al. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A. 2000;97:11038-43.
126. Hovatta I, Zapala MA, Broide RS, Schadt EE, Libiger O, Schork NJ, et al. DNA variation and brain-region specific expression profiles show different relationships between inbred mouse strains: implications for eQTL mapping studies. Genome Biol. 2007;8:R25.
127. Zapala MA, Hovatta I, Ellison JA, Wodicka L, Del Rio JA, Tennant R, et al. Adult mouse brain gene expression patterns bear an embryologic imprint. Proc Natl Acad Sci U S A. 2005;102:10357-62.
128. Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, et al. Glyoxalase 1 and glutathione reductase regulate anxiety in mice. Nature. 2005;438:662-6.
129. Panksepp J. Towards a general psychobiological theory of emotions. Behav Brain Sci. 1982;5:407-68.
130. Le Doux J. Fear and the brain: where have we been, and where are we going? Biol Psychiatry. 1998;44:1229-38.
131. Camargo EE. Brain SPECT in neurology and psychiatry. J Nucl Med. 2001;42:611-23.
132. Gray JA, McNaughton N. The neuropsychology of anxiety. 2nd ed. Padstow: Oxford University Press; 2000.
133. Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry. 2006;60:383-7.
134. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A. 1996;93:11382-8.
135. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol. 1998;72:8150-7.
136. Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A. 2003;100:1844-8.
137. Thornalley PJ. Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans. 2003;31:1343-8.
138. Chen F, Wollmer MA, Hoerndli F, Munch G, Kuhla B, Rogaev EI, et al. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101:7687-92.
139. Junaid MA, Kowal D, Barua M, Pullarkat PS, Sklower Brooks S, Pullarkat RK. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet. 2004;131A:11-7.
140. Tafti M, Petit B, Chollet D, Neidhart E, de Bilbao F, Kiss JZ, et al. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nat Genet. 2003;34:320-5.
141. Kromer SA, Kessler MS, Milfay D, Birg IN, Bunck M, Czibere L, et al. Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci. 2005;25:4375-84.
142. Thornalley PJ. Unease on the role of glyoxalase 1 in high-anxiety-related behaviour. Trends Mol Med. 2006;12:195-9.
143. Cervino AC, Li G, Edwards S, Zhu J, Laurie C, Tokiwa G, et al. Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics. 2005;86:505-17.
144. Pletcher MT, McClurg P, Batalov S, Su AI, Barnes SW, Lagler E, et al. Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol. 2004;2:e393.
145. Shifman S, Bell JT, Copley RR, Taylor MS, Williams RW, Mott R, et al. A high-resolution single nucleotide polymorphism genetic map of the mouse genome. PLoS Biol. 2006;4:e395.
146. Mozhui K, Hamre KM, Holmes A, Lu L, Williams RW. Genetic and Structural Analysis of the Basolateral Amygdala Complex in BXD Recombinant Inbred Mice. Behav Genet. 2007;37:223-43.
147. Politi P, Minoretti P, Falcone C, Martinelli V, Emanuele E. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci Lett. 2006;396:163-6.
148. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J, et al. Rgs 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm. 2006;113:1921-5.
149. Smoller JW, Acierno JS Jr, Rosenbaum JF, Biederman J, Pollack MH, Meminger S, et al. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet. 2001;105:195-206.